Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat domain 67 pseudogene (ENSG00000253410) is classified as a pseudogene, meaning it is a genomic sequence similar to an active gene but non-functional due to mutations or lack of transcription. Pseudogenes do not typically encode functional proteins, are not involved in biological processes, and are not considered therapeutic targets. The "WD repeat domain" name refers to a protein family involved in diverse cellular functions such as scaffolding and signaling, but this specific entry is a pseudogene variant, not the canonical protein-coding gene. If you need information about WD repeat domain 67 (WDR67) as a protein (if such exists), or another WD repeat family member, clarify the gene symbol or Ensembl ID for an active gene, as this entry is not a pharmacologically relevant molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat domain 67 pseudogene.